Browse Category

Stock Market News 17 December 2025

AST SpaceMobile (ASTS) Stock Slides as BlueBird 6 Launch Timeline Shifts: Latest News, Analyst Targets, and 2026 Outlook (Dec. 17, 2025)

AST SpaceMobile (ASTS) Stock Slides as BlueBird 6 Launch Timeline Shifts: Latest News, Analyst Targets, and 2026 Outlook (Dec. 17, 2025)

AST SpaceMobile, Inc. (NASDAQ: ASTS) stock was under pressure in Wednesday trading (December 17, 2025), extending a volatile stretch for the satellite-to-smartphone connectivity story that has attracted intense investor attention this year. Shares were trading around $62 in mid-afternoon, down
AST SpaceMobile (ASTS) Stock News on Dec. 17, 2025: BlueBird 6 Launch Timeline Shifts Again, While Analyst Targets Lag the Rally

AST SpaceMobile (ASTS) Stock News on Dec. 17, 2025: BlueBird 6 Launch Timeline Shifts Again, While Analyst Targets Lag the Rally

AST SpaceMobile, Inc. (NASDAQ: ASTS) stock is sharply lower in Wednesday trading (December 17, 2025) as investors refocus on one core variable that has repeatedly moved the shares this year: the timing and execution risk around the company’s next-generation satellite
Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals Limited (ASX:TLX, Nasdaq:TLX) entered the spotlight again on December 17, 2025, as TLX stock extended its December sell-off amid a fast-moving mix of clinical-trial updates, regulatory overhang, and investor litigation headlines. Telix Pharmaceuticals On the ASX, Telix shares
Go toTop